These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31199948)

  • 1. Anxiolytic impact of Apelin-13 in a rat model of Alzheimer's disease: Involvement of glucocorticoid receptor and FKBP5.
    Aminyavari S; Zahmatkesh M; Khodagholi F; Sanati M
    Peptides; 2019 Aug; 118():170102. PubMed ID: 31199948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of Apelin-13 on amyloid β25-35-induced memory deficit; Involvement of autophagy and apoptosis process.
    Aminyavari S; Zahmatkesh M; Farahmandfar M; Khodagholi F; Dargahi L; Zarrindast MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():322-334. PubMed ID: 30296470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta amyloid-induced time-dependent learning and memory impairment: involvement of HPA axis dysfunction.
    Lv J; Chen L; Zhu N; Sun Y; Pan J; Gao J; Liu J; Liu G; Tao Y
    Metab Brain Dis; 2020 Dec; 35(8):1385-1394. PubMed ID: 32860609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akebia saponin D reverses corticosterone hypersecretion in an Alzheimer's disease rat model.
    Wang Y; Shen J; Yang X; Jin Y; Yang Z; Wang R; Zhang F; Linhardt RJ
    Biomed Pharmacother; 2018 Nov; 107():219-225. PubMed ID: 30092401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crabp1 Modulates HPA Axis Homeostasis and Anxiety-like Behaviors by Altering FKBP5 Expression.
    Lin YL; Wei CW; Lerdall TA; Nhieu J; Wei LN
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term alterations of FKBP5-GR and specific microRNAs in the prefrontal cortex and hippocampus of male rats induced by adolescent stress contribute to depression susceptibility.
    Xu J; Wang R; Liu Y; Wang W; Liu D; Jiang H; Pan F
    Psychoneuroendocrinology; 2019 Mar; 101():204-215. PubMed ID: 30469088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease.
    Esmaeili MH; Bahari B; Salari AA
    Brain Res Bull; 2018 Mar; 137():265-276. PubMed ID: 29307659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model.
    Brureau A; Zussy C; Delair B; Ogier C; Ixart G; Maurice T; Givalois L
    Neurobiol Aging; 2013 May; 34(5):1426-39. PubMed ID: 23273603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inescapable footshocks induce molecular changes in the prefrontal cortex of rats in an amyloid-beta-42 model of Alzheimer's disease.
    Faborode OS; Dalle E; Mabandla MV
    Behav Brain Res; 2022 Feb; 419():113679. PubMed ID: 34826515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation.
    Mokhtari Z; Baluchnejadmojarad T; Nikbakht F; Mansouri M; Roghani M
    Biomed Pharmacother; 2017 Mar; 87():135-144. PubMed ID: 28049095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptors signaling impairment potentiates amyloid-β oligomers-induced pathology in an acute model of Alzheimer's disease.
    Canet G; Pineau F; Zussy C; Hernandez C; Hunt H; Chevallier N; Perrier V; Torrent J; Belanoff JK; Meijer OC; Desrumaux C; Givalois L
    FASEB J; 2020 Jan; 34(1):1150-1168. PubMed ID: 31914623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous galanin attenuates spatial memory impairment and decreases hippocampal β-amyloid levels in rat model of Alzheimer's disease.
    Li L; Yu L; Kong Q
    Int J Neurosci; 2013 Nov; 123(11):759-65. PubMed ID: 23687905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder.
    Fries GR; Vasconcelos-Moreno MP; Gubert C; dos Santos BT; Sartori J; Eisele B; Ferrari P; Fijtman A; Rüegg J; Gassen NC; Kapczinski F; Rein T; Kauer-Sant'Anna M
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25522387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse early life environment induces anxiety-like behavior and increases expression of FKBP5 mRNA splice variants in mouse brain.
    Ke X; Fu Q; Majnik A; Cohen S; Liu Q; Lane R
    Physiol Genomics; 2018 Nov; 50(11):973-981. PubMed ID: 30240345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer's disease model.
    Pinz MP; Dos Reis AS; Vogt AG; Krüger R; Alves D; Jesse CR; Roman SS; Soares MP; Wilhelm EA; Luchese C
    Biomed Pharmacother; 2018 Sep; 105():1006-1014. PubMed ID: 30021335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pinus halepensis essential oil attenuates the toxic Alzheimer's amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus.
    Postu PA; Sadiki FZ; El Idrissi M; Cioanca O; Trifan A; Hancianu M; Hritcu L
    Biomed Pharmacother; 2019 Apr; 112():108673. PubMed ID: 30784941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin promotes hippocampal neurogenesis via SGK1- and FKBP5-mediated glucocorticoid receptor phosphorylation in a neuroendocrine mouse model of anxiety/depression.
    Zhang K; Pan X; Wang F; Ma J; Su G; Dong Y; Yang J; Wu C
    Sci Rep; 2016 Aug; 6():30951. PubMed ID: 27502757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity.
    Pineau F; Canet G; Desrumaux C; Hunt H; Chevallier N; Ollivier M; Belanoff JK; Givalois L
    Neurobiol Aging; 2016 Sep; 45():109-122. PubMed ID: 27459932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor beta activation prevents glucocorticoid receptor-dependent effects of the central nucleus of the amygdala on behavior and neuroendocrine function.
    Weiser MJ; Foradori CD; Handa RJ
    Brain Res; 2010 Jun; 1336():78-88. PubMed ID: 20381466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.